Novel tyrosine kinase inhibitor therapy before allogeneic stem cell transplantation in patients with chronic myeloid leukemia: No evidence for increased transplant-related toxicity

Elias Jabbour, Jorge Cortes, Hagop Kantarjian, Sergio Giralt, Borje S. Andersson, Francis Giles, Elizabeth Shpall, Partow Kebriaei, Richard Champlin, Marcos De Lima*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

56 Scopus citations

Fingerprint

Dive into the research topics of 'Novel tyrosine kinase inhibitor therapy before allogeneic stem cell transplantation in patients with chronic myeloid leukemia: No evidence for increased transplant-related toxicity'. Together they form a unique fingerprint.

Medicine and Dentistry

INIS